Antimalarial Drugs
Chemistry, Development & Future Challenges

 

A Celebration of  the EU FP6 funded AntiMal project in association with the Biological and Medicinal Chemistry Sector of the Royal Society of Chemistry

 

The meeting is relevant to basic and translational scientists with an interest in medicinal chemistry, chemotherapy, pharmacology and infectious disease biology. The speakers and topics have been selected to provide a broad “state of the art” perspective that should be of particular value to younger scientists.

 

Venue: Royal College of Physicians, London

 

 

RCP Logo

 

15th and 16th March 2011

Speakers

Phil Rosenthal

University of California

 

Tim Wells

Medicines for Malaria Venture

 

Yongyuth Yuthavong

NSTDA Bangkok

 

Vicky Avery

Griffith University, Australia

 

Stephen Ward

Liverpool School of Tropical Medicine

 

Sanjeev Krishna

St Georges University Hospital

 

Elizabeth Winzeler

Novartis Research Foundation

 

David Fox

Pfizer

 

Kelly Chibale

University of Cape Town

 

Henri Vial

University of Montpellier - CNRS

 

Dennis Kyle

University of South Florida

 

Christian Doerig

EPFL-INSERM, Switzerland

 

Arnab Chatterjee

Genomics Institute of the Novartis Research Institute

 

Paul O’Neill

University of Liverpool